UBS Group AG Acquires 24,224 Shares of Hawkins, Inc. $HWKN

UBS Group AG boosted its holdings in Hawkins, Inc. (NASDAQ:HWKN) by 49.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,274 shares of the specialty chemicals company’s stock after acquiring an additional 24,224 shares during the quarter. UBS Group AG’s holdings in Hawkins were worth $10,409,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in Hawkins by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company’s stock valued at $216,754,000 after acquiring an additional 20,958 shares during the period. B. Metzler seel. Sohn & Co. AG increased its stake in Hawkins by 49.1% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 12,258 shares of the specialty chemicals company’s stock valued at $1,741,000 after acquiring an additional 4,036 shares during the period. Clark Asset Management LLC bought a new stake in Hawkins in the fourth quarter valued at about $282,000. Moran Wealth Management LLC bought a new stake in Hawkins in the fourth quarter valued at about $661,000. Finally, Farther Finance Advisors LLC increased its stake in Hawkins by 0.6% in the fourth quarter. Farther Finance Advisors LLC now owns 15,090 shares of the specialty chemicals company’s stock valued at $2,144,000 after acquiring an additional 88 shares during the period. Institutional investors own 69.71% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. BWS Financial reissued a “buy” rating and issued a $200.00 target price on shares of Hawkins in a research note on Monday, March 23rd. Weiss Ratings upgraded shares of Hawkins from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $200.00.

Hawkins Price Performance

NASDAQ:HWKN opened at $158.98 on Friday. The firm has a market cap of $3.32 billion, a PE ratio of 40.66, a price-to-earnings-growth ratio of 3.05 and a beta of 0.81. Hawkins, Inc. has a 12 month low of $117.98 and a 12 month high of $186.15. The company has a quick ratio of 1.46, a current ratio of 2.21 and a debt-to-equity ratio of 0.46. The company’s 50-day moving average price is $153.87 and its two-hundred day moving average price is $146.17.

Hawkins (NASDAQ:HWKN) last released its quarterly earnings results on Wednesday, May 13th. The specialty chemicals company reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The firm had revenue of $265.91 million during the quarter, compared to analyst estimates of $255.28 million. Hawkins had a net margin of 7.53% and a return on equity of 16.08%. On average, equities analysts anticipate that Hawkins, Inc. will post 4.29 EPS for the current fiscal year.

Hawkins Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a $0.19 dividend. The ex-dividend date is Friday, May 29th. This represents a $0.76 dividend on an annualized basis and a yield of 0.5%. Hawkins’s payout ratio is 19.44%.

Hawkins News Summary

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti raised Hawkins’ FY2028 EPS estimate to $5.35 from $5.10, signaling stronger expected long-term profitability.
• Positive Sentiment: The firm also increased several 2028 quarterly estimates, including Q1 EPS to $1.55 from $1.52 and Q2 EPS to $1.45 from $1.43, reinforcing a bullish longer-term outlook.
• Neutral Sentiment: Sidoti trimmed some near-term estimates for FY2027 and several 2027 quarters, which tempers the optimism but does not change the broader upward earnings trend.
• Neutral Sentiment: Hawkins recently reported revenue above expectations in its latest quarter, even though EPS came in slightly below consensus, leaving investors with a mixed fundamental picture.

Hawkins Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.